Net worth tracking
Login Sign Up
Become a Premium Member
  • All Opinions
  • Top Picks
  • Experts
  • Companies
  • Discover
Watch List
Home » Daily

Vaccine and treatment hopes extend bull run

Allan Tong Posted On August 24, 2020
0
0
Shares
  • Share On Facebook
  • Tweet It

Hopes for a COVID vaccine and treatment lifted markets in Toronto and New York to start the week and extend the current bull run. The S&P rallied 1% to close above 3,400 for the first time while the Nasdaq made another new high, rising 0.6%, and the Dow climbed 1.35%. The TSX gained 0.66%, lifted by the rising price of oil which itself was encouraged by the COVID news.

On Sunday, the U.S. FDA authorized a treatment that uses antibody-rich blood plasma from recovered patients. The FDA maintains that initial trials indicate the method is safe, but admits that more tests are needed. Trump celebrated the news and authorized the “emergency use” of this treatment, but the World Health Organization and America’s own Dr. Anthony Fauci have reservations about the early data. Trump is also considering fast-tracking AstraZeneca’s experimental vaccine that it’s developing with Oxford University with the aim of deploying it before the November U.S. vote. Trump has been lagging Democrat Joe Biden in presidential polls and his efforts to contain COVID has faced universal criticism.

Travel and leisure stocks shot up with American Airlines soaring 10.53% and Carnival Cruises jumping over 10%. U.S. energy rose 2.75%. Apple created another new high by breaking $500 ahead of its 4-1 stock split. In Toronto, energy rocketed up 4.3%. Chorus Aviation was among the biggest gainers, up 9.13%, while bus-maker NFI Group surged 6.82%

🛫 American Airlines Group +10.53%
🚢 Carnival Corp. +10%
🛫 Chorus Aviation Inc +9.13%
🚌 New Flyer Industries Inc. +6.82%

0
Shares
  • Share On Facebook
  • Tweet It




Trending Now
FedEx, Aritzia Inc. and 17 Stock and 3 ETF Top Picks (Jun 24-30)
Melisa R. H. July 1, 2022
3 gems from the Collision technology conference
Allan Tong June 29, 2022
Nasdaq and S&P make record closes
Read Next

Nasdaq and S&P make record closes

  • We're the Stock Chasers
    Hi! We are the Stock Chasers. We write about investing and finance tools we love. We’re passionate about fintech and we invest almost all our affiliate and advertising revenues into the development of Stockchase and Wealthica. We hope you enjoy the stock ideas and product reviews!
  • Top Reviews

    • Questrade Review: Pros & Cons of Trading with Questrade Canada (2021)
      8.5
    • Questrade vs Others | The Review Competitors Don’t Want you to Read (2021)
      7.4
    • The Ugly Truth About Identity Theft – Free Credit Report
      7
  • Popular Posts

    • FedEx, Aritzia Inc. and 17 Stock and 3 ETF Top Picks (Jun 24-30)
    • 3 gems from the Collision technology conference
    • Intertape Polymer Group and More at 52-week Highs & Lows (Jun 22-28)
    • 3 defensive stocks to find stability with your money
    • Markets slide on recession fears
  • Stock Lists

    • 3 defensive stocks to find stability with your money
      June 21, 2022
    • 3 rock stars of the mineral stocks
      June 15, 2022
    • 3 stocks to profit from revenge travel
      June 7, 2022
    • Are tech stocks alive?
      May 31, 2022
    • 3 dividend stocks to fight inflation
      May 24, 2022


  • Get $50 in free trades.


  • Stockchase neither recommends nor promotes any investment strategies.

    About us : Privacy & Terms : Contact us

© Stockchase Inc.
Press enter/return to begin your search